Agora

NASDAQ:  API

Size:  $100mm

Underwriters:  Morgan Stanley | Bank of America

Major Holders:  Soundscape Limited | Morningside | SIG | Shunwei Capital Partners | Coatue (Asia) | Easy Dynamic International

Description:  Agora’s platform provides developers simple-to-use, highly customizable and widely compatible application programming interfaces, or APIs, to embed real-time video and voice functionalities into their applications without the need to develop the technology or build the underlying infrastructure themselves.

Reference Link:  F-1

Fusion Pharmaceuticals

NASDAQ:  FUSN

Size:  $100mm

Underwriters:  Morgan Stanley | Jefferies | Cowen | Wedbush

Major Holders:  HealthCap | Adams Street Partners | Varian Medical Systems | Johnson & Johnson | CPPIB | TPG | OrbiMed | Seroba Life Sciences

Description:  Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

Reference Link:  S-1

PolyPid Ltd.

NASDAQ:  PYPD

Size:  $57.5mm

Underwriters:  Barclays | BMO | Raymond James | National Securities | AGP

Major Holders:  Aurum Ventures | Shavit Capital Management | Shirat Hachaim

Description:  PolyPid is a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using their proprietary Polymer-Lipid Encapsulation matriX, or PLEX, technology.

Reference Link:  F-1

Akouos

NASDAQ:  AKUS

Size:  $100mm

Underwriters:  Bank of America | Cowen | Piper Sandler | BTIG

Major Holders:  5AM Ventures | NEA | Pivotal bioVenture Partners Fund | Sofinnova | RA Capital Management | Novartis | Fidelity

Description:  Akouos is a precision genetic medicine company dedicated to their mission of developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.

Reference Link:  S-1